Reuters logo
BRIEF-Sun Pharma, Moebius Medical sign licensing deal to develop pain drug
December 12, 2016 / 11:09 AM / in 10 months

BRIEF-Sun Pharma, Moebius Medical sign licensing deal to develop pain drug

Dec 12 (Reuters) - Sun Pharmaceutical Industries Ltd

* Sun Pharma & Moebius Medical sign exclusive global licensing deal

* Deal to develop novel liposomal non-opiod pain product for osteoarthritis

* Moebius medical will get upfront payment, development-based,sales-based milestone payments, tiered royalties on sales from co

* To fund further development of MM-II

* Sun Pharma has worldwide commercialization & manufacturing rights

* Moebius Medical will conduct requisite pre-clinical studies

* Moebius medical will assume responsibility for product development and manufacturing through the end of phase-ii studies Source text: bit.ly/2hl91S1 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below